Linked to 914 companies since Feb 1994. A filing names it for 57% of those. The rest come from a text search, which also finds a firm on the other side of a deal.
These figures describe clients, not conduct. A lawyer or firm can serve many companies that later had trouble for reasons that have nothing to do with their work, and nothing here says any lawyer or firm did anything wrong.
60 of these companies later showed signs of SEC or DOJ scrutiny and had another red flag. Comparable companies would show 57.3, so that is 1.05× what you would expect.
Each bar’s tick marks 1×, no more than comparable companies. A colored bar has q below 0.05, the usual bar.
| What came later | Companies | Expected | × expected | q |
|---|---|---|---|---|
| SEC or DOJ scrutiny and another red flag | 60 | 57.3 | 1.05 | 1.000 |
| SEC or DOJ scrutiny | 90 | 92.5 | 0.97 | 1.000 |
| Stopped filing, and the SEC acted | 4 | 27.8 | 0.14 | 1.000 |
| Shares fell 95% from their high | 150 | 164.8 | 0.91 | 1.000 |
| Two or more different red flags | 177 | 157.1 | 1.13 | 0.471 |
| Said its accounts could not be relied on | 164 | 142.0 | 1.15 | 1.000 |
| Bankruptcy or receivership | 45 | 38.9 | 1.16 | 0.864 |
| Restructuring or accelerated debt | 235 | 179.2 | 1.31 | 0.002 |
| Delisting notice | 416 | 329.8 | 1.26 | <0.001 |
| SEC accounting enforcement release | 21 | 19.7 | 1.07 | 1.000 |
| An SEC release or DOJ statement names it, an officer or its stock | 51 | 48.1 | 1.06 | 1.000 |
| # | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Paul KinsellaRopes & Gray | 54 | 89% | 11 | 4.8 | 2.28 | 0.589 | 1.70 | 0.39 | 0.63 |
| 2 | David A. FineRopes & Gray | 17 | 77% | 5 | 1.2 | 4.22 | 0.589 | 2.95 | 1.71 | 0.00 |
| 3 | Paul D. TroppRopes & Gray | 108 | 75% | 4 | 4.4 | 0.92 | 1.000 | 0.86 | 0.00 | 0.93 |
| 4 | Christopher J. CapuzziRopes & Gray | 56 | 70% | 2 | 2.0 | 1.00 | 1.000 | 0.79 | 0.00 | 0.86 |
| 5 | Marc A. RubensteinRopes & Gray | 48 | 58% | 3 | 3.6 | 0.84 | 1.000 | 0.64 | 0.56 | 1.25 |
| 6 | Craig E. MarcusRopes & Gray | 45 | 76% | 1 | 2.3 | 0.44 | 1.000 | 0.69 | 0.00 | 0.91 |
| 7 | Patrick O BrienRopes & Gray | 45 | 82% | 4 | 3.2 | 1.25 | 1.000 | 0.98 | 0.00 | 1.09 |
| 8 | Keith F. HigginsRopes & Gray | 35 | 83% | 5 | 3.5 | 1.44 | 1.000 | 0.86 | 0.00 | 0.53 |
| 9 | Thomas HoldenRopes & Gray | 35 | 66% | 3 | 2.1 | 1.45 | 1.000 | 0.95 | 0.00 | 1.03 |
| 10 | Zachary BlumeRopes & Gray | 31 | 84% | 1 | 1.3 | 0.76 | 1.000 | 1.30 | 1.69 | 0.51 |
| 11 | David C. ChapinRopes & Gray | 30 | 27% | 2 | 1.8 | 1.10 | 1.000 | 0.61 | 0.00 | 1.00 |
| 12 | Alfred O. RoseRopes & Gray | 27 | 26% | 4 | 1.7 | 2.30 | 1.000 | 1.30 | 0.00 | 2.10 |
| 13 | Brian C. ErbRopes & Gray | 27 | 70% | 1 | 1.8 | 0.54 | 1.000 | 0.31 | 0.80 | 0.33 |
| 14 | Julie H. JonesRopes & Gray | 25 | 72% | 2 | 2.8 | 0.71 | 1.000 | 0.41 | 0.00 | 1.26 |
| 15 | Rachel PhillipsRopes & Gray | 23 | 78% | 1 | 1.0 | 1.02 | 1.000 | 1.56 | 0.00 | 1.99 |
| 16 | Jane D. GoldsteinRopes & Gray | 22 | 55% | 1 | 1.3 | 0.79 | 1.000 | 0.41 | 0.00 | 0.51 |
| 17 | Christopher D. ComeauRopes & Gray | 21 | 91% | 1 | 1.0 | 1.02 | 1.000 | 0.66 | 0.00 | 0.48 |
| 18 | William M. ShieldsRopes & Gray | 21 | 48% | 1 | 1.8 | 0.55 | 1.000 | 0.69 | 0.00 | 0.00 |
| 19 | Paul W. Boltz Jr.Ropes & Gray | 17 | 88% | 1 | 1.0 | 0.97 | 1.000 | 1.07 | 1.29 | 0.82 |
| 20 | DAVID B. WALEKRopes & Gray | 14 | 93% | 2 | 1.4 | 1.47 | 1.000 | 0.90 | 0.00 | 1.20 |
| 21 | Tara FisherRopes & Gray | 14 | 79% | 2 | 0.5 | 3.72 | 1.000 | 1.97 | 0.00 | 0.29 |
| 22 | Michael D. BeauvaisRopes & Gray | 11 | 73% | 1 | 0.8 | 1.34 | 1.000 | 0.90 | 0.00 | 0.89 |
| 23 | Mary E. WeberRopes & Gray | 10 | 80% | 2 | 1.5 | 1.30 | 1.000 | 0.86 | 0.00 | 1.63 |
| 24 | John B. AyerRopes & Gray | 8 | 50% | 1 | 0.4 | 2.36 | 1.000 | 2.54 | 0.00 | 1.19 |
| 25 | Jason FreedmanRopes & Gray | 7 | 29% | 1 | 0.3 | 3.92 | 1.000 | 6.99 | 0.00 | 0.00 |
| 26 | Joel F. FreedmanRopes & Gray | 33 | 42% | 0 | 2.2 | 0.00 | — | 0.00 | 0.97 | 1.34 |
| 27 | Carl MarcellinoRopes & Gray | 32 | 69% | 0 | 1.4 | 0.00 | — | 0.41 | 0.00 | 1.20 |
| 28 | William J. MichenerRopes & Gray | 21 | 91% | 0 | 0.6 | 0.00 | — | 0.00 | 0.00 | 1.26 |
| 29 | Thomas J. DanielskiRopes & Gray | 19 | 95% | 0 | 0.8 | 0.00 | — | 0.00 | 0.00 | 0.93 |
| 30 | Emily OldshueRopes & Gray | 18 | 83% | 0 | 0.6 | 0.00 | — | 1.28 | 0.00 | 0.26 |
| 31 | Thomas FraserRopes & Gray | 17 | 65% | 0 | 0.6 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| 32 | Daniel S. EvansRopes & Gray | 12 | 50% | 0 | 0.8 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| 33 | Jay J. KimRopes & Gray | 11 | 27% | 0 | 0.5 | 0.00 | — | 1.96 | 0.00 | 0.86 |
| 34 | Steven A. WilcoxRopes & Gray | 11 | 55% | 0 | 0.9 | 0.00 | — | 0.00 | 0.00 | 1.27 |
| 35 | Nicholas RoperRopes & Gray | 7 | 100% | 0 | 0.3 | 0.00 | — | 0.00 | 0.00 | 0.80 |
| 36 | Richard J. MorrisonRopes & Gray | 7 | 71% | 0 | 0.4 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| 37 | LAUREN I. NORTONRopes & Gray | 6 | 100% | 0 | 0.5 | 0.00 | — | 1.27 | 0.00 | 0.00 |
| 38 | Lisa M. KahleRopes & Gray | 6 | 100% | 0 | 0.6 | 0.00 | — | 0.00 | 0.00 | 0.91 |
| 39 | Amanda McGrady MorrisonRopes & Gray | 5 | 40% | 0 | 0.2 | 0.00 | — | 2.69 | 0.00 | 0.00 |
| 40 | Benjamin KozikRopes & Gray | 5 | 100% | 0 | 0.2 | 0.00 | — | 0.00 | 0.00 | 1.60 |
| 41 | Geoffrey B. DavisRopes & Gray | 5 | 40% | 0 | 0.4 | 0.00 | — | 0.00 | 2.83 | 1.85 |
| 42 | Philip KassinRopes & Gray | 5 | 20% | 0 | 0.1 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| 43 | Sarah H. YoungRopes & Gray | 5 | 100% | 0 | 0.1 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| 44 | Tom FraserRopes & Gray | 5 | 60% | 0 | 0.3 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| How it is known | |||
|---|---|---|---|
| Stark Novus Financial Inc.NRDE (last ticker on record) | Jan 2019 | Named in SEC correspondence |
|
| Roadrunner Transportation Systems, Inc.RRTS (last ticker on record) | Sep 2008 | Text search only |
|
| SELLAS Life Sciences Group, Inc.SLS (last ticker on record) | Oct 2007 | Named in SEC correspondence |
|
| SYNCHRONOSS TECHNOLOGIES INCSNCR (last ticker on record) | Feb 2006 | Named in SEC correspondence |
|
| Avaya Holdings Corp.AVYA (last ticker on record) | Jun 2011 | Named in a filing |
|
| EyePoint, Inc.EYPT (last ticker on record) | Jun 2006 | Named in SEC correspondence |
|
| LadRx CorpLADX (last ticker on record) | Jul 2008 | Text search only |
|
| MAGNA ENTERTAINMENT CORPMECAQ (last ticker on record) | Oct 2001 | Text search only |
|
| Sequential Brands Group, Inc.SQBG (last ticker on record) | Sep 2015 | Text search only |
|
| SERACARE LIFE SCIENCES INCSRLS (last ticker on record) | Jun 2008 | Named in SEC correspondence |
|
| SkinHealth Systems Inc.SKIN (last ticker on record) | Aug 2020 | Text search only |
|
| XEROX CORPXRX (last ticker on record) | Oct 2009 | Text search only |
|
| Bioventus Inc.BVS (last ticker on record) | Oct 2020 | Text search only |
|
| China Shenghuo Pharmaceutical Holdings IncKUN (last ticker on record) | Dec 2006 | Text search only |
|
| EDUCATION MANAGEMENT CorpEDMC (last ticker on record) | Apr 2009 | Text search only |
|
| INFINITY PHARMACEUTICALS, INC.INFI (last ticker on record) | Jul 2006 | Text search only |
|
| Party City Holdco Inc.PRTY (last ticker on record) | Jan 2014 | Named in SEC correspondence |
|
| Sage Therapeutics, Inc.SAGE (last ticker on record) | Mar 2014 | Named in a filing |
|
| Sonder Holdings Inc.SOND (last ticker on record) | Sep 2020 | Named in SEC correspondence |
|
| Virgin Orbit Holdings, Inc.VORB (last ticker on record) | Feb 2021 | Named in SEC correspondence |
|
| XERIUM TECHNOLOGIES INCXRM (last ticker on record) | Apr 2004 | Named in a filing |
|
| ACCURAY INCARAY (last ticker on record) | Nov 2006 | Text search only |
|
| Akili, Inc.AKLI (last ticker on record) | Apr 2021 | Named in SEC correspondence |
|
| ALLURION TECHNOLOGIES, INC.ALUR (last ticker on record) | May 2024 | Text search only |
|
| Alphatec Holdings, Inc.ATEC (last ticker on record) | Mar 2006 | Text search only |
|
| American Strategic Investment Co.NYC (last ticker on record) | Jan 2014 | Text search only |
|
| ARGOS THERAPEUTICS INCARGS (last ticker on record) | Nov 2013 | Text search only |
|
| AROTECH CORPARTX (last ticker on record) | Jan 1997 | Named in a filing |
|
| Astra Space, Inc.ASTR (last ticker on record) | Jul 2020 | Named in SEC correspondence |
|
| Butterfly Network, Inc.BFLY (last ticker on record) | Feb 2020 | Named in SEC correspondence |
|
| China Medical Technologies, Inc.CMED (last ticker on record) | Nov 2011 | Named in SEC correspondence |
|
| Claritev CorpCTEV (last ticker on record) | Jul 2020 | Text search only |
|
| Clever Leaves Holdings Inc.CLVR (last ticker on record) | Aug 2020 | Text search only |
|
| CytomX Therapeutics, Inc.CTMX (last ticker on record) | Jul 2015 | Text search only |
|
| DAVIDsTEA Inc.DTEA (last ticker on record) | Dec 2014 | Named in SEC correspondence |
|
| DELTA FINANCIAL CORPDFCLQ (last ticker on record) | Jul 2001 | Text search only |
|
| ENDEAVOUR INTERNATIONAL CORPENDRQ (last ticker on record) | May 2014 | Text search only |
|
| EPIRUS Biopharmaceuticals, Inc.EPRS (last ticker on record) | Dec 2004 | Named in a filing |
|
| FiberTower CORPFTWR (last ticker on record) | Jul 1997 | Named in SEC correspondence |
|
| GoodRx Holdings, Inc.GDRX (last ticker on record) | Jul 2020 | Text search only |
|
| iHeartMedia, Inc.IHRT (last ticker on record) | May 2007 | Named in SEC correspondence |
|
| IRONWOOD PHARMACEUTICALS INCIRWD (last ticker on record) | Nov 2009 | Named in SEC correspondence |
|
| Movella Holdings Inc.MVLA (last ticker on record) | Jan 2021 | Named in SEC correspondence |
|
| Nerdy Inc.NRDY (last ticker on record) | Sep 2020 | Named in SEC correspondence |
|
| NOVAVAX INCNVAX (last ticker on record) | Aug 2004 | Named in SEC correspondence |
|
| OSCIENT PHARMACEUTICALS CORPOSCI (last ticker on record) | Jul 1995 | Named in SEC correspondence |
|
| Owlet, Inc.OWLT (last ticker on record) | Jul 2020 | Named in SEC correspondence |
|
| Quanterix CorpQTRX (last ticker on record) | Jul 2017 | Named in SEC correspondence |
|
| Rockley Photonics Holdings LtdRKLY (last ticker on record) | Apr 2021 | Named in SEC correspondence |
|
| RVL Pharmaceuticals plcRVLP (last ticker on record) | May 2018 | Named in SEC correspondence |
|